Effects of Kasugamycin on the Translatome of Escherichia coli. 2017

Christian Lange, and Matthias Lehr, and Karolin Zerulla, and Petra Ludwig, and Jens Schweitzer, and Tino Polen, and Volker F Wendisch, and Jörg Soppa
Goethe University, Biocentre, Institute for Molecular Biosciences, Frankfurt, Germany.

It is long known that Kasugamycin inhibits translation of canonical transcripts containing a 5'-UTR with a Shine Dalgarno (SD) motif, but not that of leaderless transcripts. To gain a global overview of the influence of Kasugamycin on translation efficiencies, the changes of the translatome of Escherichia coli induced by a 10 minutes Kasugamycin treatment were quantified. The effect of Kasugamycin differed widely, 102 transcripts were at least twofold more sensitive to Kasugamycin than average, and 137 transcripts were at least twofold more resistant, and there was a more than 100-fold difference between the most resistant and the most sensitive transcript. The 5'-ends of 19 transcripts were determined from treated and untreated cultures, but Kasugamycin resistance did neither correlate with the presence or absence of a SD motif, nor with differences in 5'-UTR lengths or GC content. RNA Structure Logos were generated for the 102 Kasugamycin-sensitive and for the 137 resistant transcripts. For both groups a short Shine Dalgarno (SD) motif was retrieved, but no specific motifs associated with resistance or sensitivity could be found. Notably, this was also true for the region -3 to -1 upstream of the start codon and the presence of an extended SD motif, which had been proposed to result in Kasugamycin resistance. Comparison of the translatome results with the database RegulonDB showed that the transcript with the highest resistance was leaderless, but no further leaderless transcripts were among the resistant transcripts. Unexpectedly, it was found that translational coupling might be a novel feature that is associated with Kasugamycin resistance. Taken together, Kasugamycin has a profound effect on translational efficiencies of E. coli transcripts, but the mechanism of action is different than previously described.

UI MeSH Term Description Entries
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside
D001482 Base Composition The relative amounts of the PURINES and PYRIMIDINES in a nucleic acid. Base Ratio,G+C Composition,Guanine + Cytosine Composition,G+C Content,GC Composition,GC Content,Guanine + Cytosine Content,Base Compositions,Base Ratios,Composition, Base,Composition, G+C,Composition, GC,Compositions, Base,Compositions, G+C,Compositions, GC,Content, G+C,Content, GC,Contents, G+C,Contents, GC,G+C Compositions,G+C Contents,GC Compositions,GC Contents,Ratio, Base,Ratios, Base
D014176 Protein Biosynthesis The biosynthesis of PEPTIDES and PROTEINS on RIBOSOMES, directed by MESSENGER RNA, via TRANSFER RNA that is charged with standard proteinogenic AMINO ACIDS. Genetic Translation,Peptide Biosynthesis, Ribosomal,Protein Translation,Translation, Genetic,Protein Biosynthesis, Ribosomal,Protein Synthesis, Ribosomal,Ribosomal Peptide Biosynthesis,mRNA Translation,Biosynthesis, Protein,Biosynthesis, Ribosomal Peptide,Biosynthesis, Ribosomal Protein,Genetic Translations,Ribosomal Protein Biosynthesis,Ribosomal Protein Synthesis,Synthesis, Ribosomal Protein,Translation, Protein,Translation, mRNA,mRNA Translations
D020121 5' Untranslated Regions The sequence at the 5' end of the messenger RNA that does not code for product. This sequence contains the ribosome binding site and other transcription and translation regulating sequences. 5'UTR,Leader Sequences, mRNA,Leader mRNA Sequences,mRNA Leader Sequences,5' UTR,5' UTRs,5' Untranslated Region,5'UTRs,Leader Sequence, mRNA,Leader mRNA Sequence,Region, 5' Untranslated,Regions, 5' Untranslated,Sequence, Leader mRNA,Sequence, mRNA Leader,Sequences, Leader mRNA,Sequences, mRNA Leader,UTR, 5',UTRs, 5',Untranslated Region, 5',Untranslated Regions, 5',mRNA Leader Sequence,mRNA Sequence, Leader,mRNA Sequences, Leader
D029968 Escherichia coli Proteins Proteins obtained from ESCHERICHIA COLI. E coli Proteins
D030562 Databases, Protein Databases containing information about PROTEINS such as AMINO ACID SEQUENCE; PROTEIN CONFORMATION; and other properties. Amino Acid Sequence Databases,Databases, Amino Acid Sequence,Protein Databases,Protein Sequence Databases,SWISS-PROT,Protein Structure Databases,SwissProt,Database, Protein,Database, Protein Sequence,Database, Protein Structure,Databases, Protein Sequence,Databases, Protein Structure,Protein Database,Protein Sequence Database,Protein Structure Database,SWISS PROT,Sequence Database, Protein,Sequence Databases, Protein,Structure Database, Protein,Structure Databases, Protein

Related Publications

Christian Lange, and Matthias Lehr, and Karolin Zerulla, and Petra Ludwig, and Jens Schweitzer, and Tino Polen, and Volker F Wendisch, and Jörg Soppa
December 1978, Journal of bacteriology,
Christian Lange, and Matthias Lehr, and Karolin Zerulla, and Petra Ludwig, and Jens Schweitzer, and Tino Polen, and Volker F Wendisch, and Jörg Soppa
January 1972, Nature: New biology,
Christian Lange, and Matthias Lehr, and Karolin Zerulla, and Petra Ludwig, and Jens Schweitzer, and Tino Polen, and Volker F Wendisch, and Jörg Soppa
November 1975, The Journal of antibiotics,
Christian Lange, and Matthias Lehr, and Karolin Zerulla, and Petra Ludwig, and Jens Schweitzer, and Tino Polen, and Volker F Wendisch, and Jörg Soppa
February 1973, Biochemistry,
Christian Lange, and Matthias Lehr, and Karolin Zerulla, and Petra Ludwig, and Jens Schweitzer, and Tino Polen, and Volker F Wendisch, and Jörg Soppa
August 1987, Biochimie,
Christian Lange, and Matthias Lehr, and Karolin Zerulla, and Petra Ludwig, and Jens Schweitzer, and Tino Polen, and Volker F Wendisch, and Jörg Soppa
June 2016, Antibiotics (Basel, Switzerland),
Christian Lange, and Matthias Lehr, and Karolin Zerulla, and Petra Ludwig, and Jens Schweitzer, and Tino Polen, and Volker F Wendisch, and Jörg Soppa
February 1983, Journal of bacteriology,
Christian Lange, and Matthias Lehr, and Karolin Zerulla, and Petra Ludwig, and Jens Schweitzer, and Tino Polen, and Volker F Wendisch, and Jörg Soppa
February 1973, Journal of bacteriology,
Christian Lange, and Matthias Lehr, and Karolin Zerulla, and Petra Ludwig, and Jens Schweitzer, and Tino Polen, and Volker F Wendisch, and Jörg Soppa
January 1970, Science (New York, N.Y.),
Christian Lange, and Matthias Lehr, and Karolin Zerulla, and Petra Ludwig, and Jens Schweitzer, and Tino Polen, and Volker F Wendisch, and Jörg Soppa
August 1980, FEBS letters,
Copied contents to your clipboard!